Table 1 Demographic and clinical characteristics of patients
From: Nomogram predictive model for in-hospital mortality risk in elderly ICU patients with urosepsis
Variable | ALL | Training cohort | Validation cohort |
|---|---|---|---|
N | 1251 | 875 | 376 |
Sex(%) | Â | Â | Â |
 Male | 503 (40.2%) | 363 (41.5%) | 140 (37.2%) |
 Female | 748 (59.8%) | 512 (58.5%) | 236 (62.8%) |
Race(%) | Â | Â | Â |
 white | 861 (68.8%) | 609 (69.6%) | 252 (67.0%) |
 black | 133 (10.6%) | 92 (10.5%) | 41 (10.9%) |
 other | 257 (20.5%) | 174 (19.9%) | 83 (22.1%) |
Age | 79.0 [73.0,86.0] | 79.0 [73.0,86.0] | 79.5 [73.0,87.0] |
GCS | 13.0 [8.00,14.0] | 13.0 [9.00,14.0] | 13.0 [8.00,14.0] |
SAPS-II | 43.0 [36.0,51.0] | 43.0 [36.0,51.0] | 43.0 [36.0,51.0] |
APACHE-II | 23.0[18.0,28.0] | 23.0[19.0,28.0] | 22.0[18.0,27.0] |
SOFA | 6.00[4.00,8.00] | 6.00[4.00,8.00] | 6.00[4.00,8.00] |
Charlson | 7.00 [6.00,9.00] | 7.00 [6.00,9.00] | 7.00 [6.00,9.00] |
Comorbidities | Â | Â | Â |
 Urolithiasis(%) |  |  |  |
  No | 1221 (97.6%) | 860 (98.3%) | 361 (96.0%) |
  Yes | 30 (2.40%) | 15 (1.71%) | 15 (3.99%) |
 Malignant cancer(%) |  |  |  |
  No | 1083 (86.6%) | 748 (85.5%) | 335 (89.1%) |
  Yes | 168 (13.4%) | 127 (14.5%) | 41 (10.9%) |
 Congestive heart failure(%) |  |  |  |
  No | 723 (57.8%) | 516 (59.0%) | 207 (55.1%) |
  Yes | 528 (42.2%) | 359 (41.0%) | 169 (44.9%) |
 Diabetes(%) |  |  |  |
  No | 794 (63.5%) | 567 (64.8%) | 227 (60.4%) |
  Yes | 457 (36.5%) | 308 (35.2%) | 149 (39.6%) |
 Hypertension(%) |  |  |  |
  No | 1223 (97.8%) | 858 (98.1%) | 365 (97.1%) |
  Yes | 28 (2.24%) | 17 (1.94%) | 11 (2.93%) |
 Severe liver disease(%) |  |  |  |
  No | 1203 (96.2%) | 846 (96.7%) | 357 (94.9%) |
  Yes | 48 (3.84%) | 29 (3.31%) | 19 (5.05%) |
 Obesity(%) |  |  |  |
  No | 1119 (89.4%) | 785 (89.7%) | 334 (88.8%) |
  Yes | 132 (10.6%) | 90 (10.3%) | 42 (11.2%) |
 Chronic pulmonary disease(%) |  |  |  |
  No | 949 (75.9%) | 652 (74.5%) | 297 (79.0%) |
  Yes | 302 (24.1%) | 223 (25.5%) | 79 (21.0%) |
 Renal disease(%) |  |  |  |
  No | 821 (65.6%) | 575 (65.7%) | 246 (65.4%) |
  Yes | 430 (34.4%) | 300 (34.3%) | 130 (34.6%) |
Laboratory test | Â | Â | Â |
 WBC(K/uL) | 13.5 [9.50,18.4] | 13.4 [9.50,18.2] | 13.6 [9.70,18.8] |
 Neutrophil(%) | 75.2 [65.4,83.6] | 75.2 [66.5,84.0] | 74.8 [63.2,83.0] |
 Lymphocytes(%) | 14.6 [8.00,23.1] | 14.6 [7.80,22.5] | 15.0 [8.80,24.3] |
 Hematocrit(g/dL) | 29.8 [25.0,34.6] | 29.8 [25.0,34.5] | 29.7 [24.9,35.2] |
 Hemoglobin(g/dL) | 9.40 [7.90,11.1] | 9.40 [7.90,11.1] | 9.50 [7.90,11.2] |
 Platelets(K/uL) | 173 [121,233] | 174 [121,230] | 171 [121,237] |
 RDW(%) | 15.5 [14.2,17.3] | 15.5 [14.2,17.2] | 15.5 [14.3,17.5] |
 Creatinine(mg/dL) | 1.30 [0.90,2.00] | 1.20 [0.90,2.00] | 1.30 [0.90,1.90] |
 Glucose(mg/dL) | 149 [118,200] | 150 [121,202] | 145 [115,198] |
 Albumin(g/dL) | 3.60 [3.10,4.00] | 3.60 [3.10,4.00] | 3.60 [3.20,4.00] |
 Sodium(mmol/L) | 140 [137,143] | 141 [137,144] | 140 [138,143] |
 Calcium(mg/dL) | 8.20 [7.70,8.70] | 8.20 [7.70,8.70] | 8.30 [7.80,8.70] |
 Chloride(mmol/L) | 105 [100,109] | 105 [100,109] | 105 [101,109] |
 Potassium(mmol/L) | 4.50 [4.10,5.10] | 4.50 [4.10,5.10] | 4.50 [4.10,5.10] |
 Ph | 7.40 [7.30,7.40] | 7.40 [7.30,7.40] | 7.40 [7.30,7.40] |
 Po2(mmHg) | 70.0 [43.5,138] | 70.0 [44.0,137] | 70.0 [43.0,142] |
 Pco2(mmHg) | 41.0 [35.0,47.0] | 41.0 [35.0,47.0] | 40.0 [34.8,47.0] |
 Base excess(mmol/L) | 0.00 [-4.00,1.00] | 0.00 [-4.00,1.00] | 0.00 [-4.00,1.00] |
 Lac(mmol/L) | 1.70 [1.20,2.50] | 1.70 [1.20,2.50] | 1.70 [1.30,2.40] |
Urine RBC(#/hpf) | 3.00 [1.00,12.0] | 3.00 [1.00,12.0] | 4.00 [1.00,12.0] |
Urine WBC(#/hpf) | 7.00 [2.00,32.0] | 7.00 [2.00,34.5] | 7.00 [2.00,27.2] |
Input total(ml) | 6410 [3260,12405] | 6400 [3316,12100] | 6460 [3200,13055] |
Urine blood(%) | Â | Â | Â |
 Negative | 647 (51.7%) | 459 (52.5%) | 188 (50.0%) |
 Positive | 604 (48.3%) | 416 (47.5%) | 188 (50.0%) |
Urine ketone(%) | Â | Â | Â |
 Negative | 415 (33.2%) | 305 (34.9%) | 110 (29.3%) |
 Positive | 836 (66.8%) | 570 (65.1%) | 266 (70.7%) |
Urine protein(%) | Â | Â | Â |
 Negative | 415 (33.2%) | 281 (32.1%) | 134 (35.6%) |
 Positive | 836 (66.8%) | 594 (67.9%) | 242 (64.4%) |
Urine catheter(%) | Â | Â | Â |
 No | 908 (72.6%) | 635 (72.6%) | 273 (72.6%) |
 Yes | 343 (27.4%) | 240 (27.4%) | 103 (27.4%) |
Antibiotic(%) | Â | Â | Â |
 No | 254 (20.3%) | 172 (19.7%) | 82 (21.8%) |
 Yes | 997 (79.7%) | 703 (80.3%) | 294 (78.2%) |
Invasive ventlation(%) | Â | Â | Â |
 No | 756 (60.4%) | 536 (61.3%) | 220 (58.5%) |
 Yes | 495 (39.6%) | 339 (38.7%) | 156 (41.5%) |
Urologic surgery(%) | Â | Â | Â |
 No | 1202 (96.1%) | 360 (95.7%) | 842 (96.2%) |
 Yes | 49 (3.92%) | 16 (4.26%) | 33 (3.77%) |
Outcome | Â | Â | Â |
 Mortality hospital(%) |  |  |  |
  No | 1016 (81.2%) | 709 (81.0%) | 307 (81.6%) |
  Yes | 235 (18.8%) | 166 (19.0%) | 69 (18.4%) |